Plasminogen activator inhibitor-1 and Restenosis

被引：9
|
作者：
Garg, Nadish
Fay, William P.
机构：
[1] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO USA
[2] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO USA
[3] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA
来源：
CURRENT DRUG TARGETS | 2007年 / 8卷 / 09期
关键词：
D O I：
10.2174/138945007781662355
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Despite the introduction of drug-eluting stents; restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
引用
收藏
页码：1003 / 1006
页数：4
相关论文
共 50 条
  • [21] Tissue plasminogen activator and plasminogen activator inhibitor-1 in human choledochal bile
    Lee, SJ
    Cho, JS
    Chung, JP
    Lee, KS
    Chung, JB
    Lee, SI
    Moon, YM
    Kang, JK
    Kwon, SW
    Chi, HS
    Choi, JR
    Song, KS
    [J]. YONSEI MEDICAL JOURNAL, 2000, 41 (01) : 119 - 122
  • [22] Tissue plasminogen activator and plasminogen activator inhibitor-1 in human choledochal bile
    Lee, SJ
    Cho, JS
    Chung, JP
    Lee, KS
    Chung, JB
    Lee, SI
    Moon, YM
    Kang, JK
    Park, IS
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A19 - A19
  • [23] RELATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 CONCENTRATION IN DIFFERENT PLASMA SAMPLES
    SIEGERT, G
    FRITZ, T
    RUNGE, E
    [J]. FIBRINOLYSIS, 1994, 8 : 154 - 156
  • [24] Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels
    Kathiresan, S
    Gabriel, SB
    Yang, Q
    Lochner, AL
    Larson, MG
    Levy, D
    Tofler, GH
    Hirschhorn, JN
    O'Donnell, CJ
    [J]. CIRCULATION, 2005, 112 (12) : 1728 - 1735
  • [25] Gene-based Haplotypes at the plasminogen activator inhibitor-1 locus are associated with circulating plasminogen activator inhibitor-1 levels.
    Kathiresan, S
    Yang, Q
    Lochner, A
    Larson, MG
    Tofler, GH
    Gabriel, S
    O'Donnell, CJ
    [J]. CIRCULATION, 2004, 109 (07) : E77 - E77
  • [26] Tissue plasminogen activator and plasminogen activator inhibitor-1 promote tissue integration of biomaterial
    Hessenauer, M.
    Reichel, C. A.
    Berghaus, A.
    Strieth, S.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 : 8 - 8
  • [27] NEUTRALIZATION BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 OF MUTANTS OF TISSUE PLASMINOGEN-ACTIVATOR
    BERGUM, PW
    ERICKSON, LA
    [J]. ENZYME, 1988, 40 (2-3) : 122 - 129
  • [28] Genetic Architecture of Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1
    Asselbergs, Folkert W.
    Pattin, Kristine
    Snieder, Harold
    Hillege, Hans L.
    van Gilst, Wiek H.
    Moore, Jason H.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (06): : 562 - 568
  • [29] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    [J]. DIABETES, 1994, 43 : A197 - A197
  • [30] Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1
    Stefansson, S
    Petitclerc, E
    Wong, MKK
    McMahon, GA
    Brooks, PC
    Lawrence, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) : 8135 - 8141
12345